Said Dermime

Hamad Medical Corporation, Qatar 0000-0002-5526-7496

Said Dermime graduated with B.S. Degree in biological sciences from the University of Constantine, Constantine, Algeria, in 1985. He then received his M.S. and PhD. degrees in immunology from Salford University, Manchester, UK, in 1987 and 1992, respectively. After that, he joined the National Cancer Institute, Milan, Italy, for a period of 2 years as Postdoctoral Fellow and the NHLBI, NIH, Bethesda, USA, for another 2-year fellowship under an NIH Fogarty International Award. To gain industrial experience, he worked at PPL Therapeutics Limited, London, UK, and COBRA Therapeutics Ltd., UK, for a period of 2 years. Dr. Dermime was appointed in 1998 at the PICR, Manchester, UK, as a lymphoma-cancer-vaccine Team Leader for 4 years. Subsequently, he established and led the Tumor Immunology Section at KFSHRC, Riyadh, KSA, for a period of 6 years as a senior scientist. Dr. Dermime joined after that the Dasman Diabetes Institute in Kuwait in 2008 to establish and lead the Department of Biomedical Research and to head the Immunology and Innovative Cell Therapy Unit. In 2012, he joined King Fahad Specialist Hospital in Dammam, Saudi Arabia, to establish the Biomedical Research Facility and to head the Immunology and Innovative Cell therapy Program. Recently, he was recruited by the NCCCR, Hamad Medical Corporation, Doha, Qatar, to establish and lead the Translational Cancer Research Facility. He is a Member of several international scientific societies and active Member of the editorial board of some immunology journals and Member of scientific boards of some international organizations. Dr. Dermime supervised several Ph.D. and M.S. students and received several research grants from different organizations such as Christie Hospital Endowment funds (UK), ASTF (UAE), KACST (KSA), and KFAS (Kuwait). Dr. Dermime published over 42 peer-reviewed articles in high impact factor journal such as Blood, Cancer Research, Journal of Immunology, Clinical Cancer Research, Neoplasia, and Breast Cancer Research.

Biography Updated on 6 August 2016

Scholarly Contributions [Data Provided by ]